| spelling |
oapen-20.500.12657-524342022-01-15T02:49:17Z Vaccines, Medicines and COVID-19 Velásquez, Germán COVID-19 Coronavirus pandemic access to affordable essential medicines Vaccine nationalism and vaccine safety World Health Organization reform Biosimilars and biotherapeutics COVAX Facility COVID-19 diagnostics Global health preparedness Article 19 of the WHO Constitution access to COVID-19 tools (ACT) accelerator Framework Convention on Tobacco Control (FCTC) Inter-Governmental Working Group (IGWG) Patentability criteria Pharmaceutical sovereignty Research and Development (R&D) Universal Health Coverage (UHC) World Health Assembly (WHA) World Trade Organization (WTO) non-governmental organization (NGOs) Open Access bic Book Industry Communication::M Medicine::MB Medicine: general issues::MBN Public health & preventive medicine bic Book Industry Communication::M Medicine::MB Medicine: general issues::MBP Health systems & services bic Book Industry Communication::P Mathematics & science::PN Chemistry bic Book Industry Communication::T Technology, engineering, agriculture::TC Biochemical engineering::TCB Biotechnology bic Book Industry Communication::T Technology, engineering, agriculture::TG Mechanical engineering & materials::TGM Materials science This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19. 2022-01-14T13:41:34Z 2022-01-14T13:41:34Z 2022 book ONIX_20220114_9783030891251_26 9783030891251 https://library.oapen.org/handle/20.500.12657/52434 eng SpringerBriefs in Public Health application/pdf n/a 978-3-030-89125-1.pdf https://link.springer.com/978-3-030-89125-1 Springer Nature Springer International Publishing 10.1007/978-3-030-89125-1 10.1007/978-3-030-89125-1 6c6992af-b843-4f46-859c-f6e9998e40d5 be29a9b7-e208-4adb-8f52-ab11028c5720 9783030891251 Springer International Publishing 117 [grantnumber unknown] open access
|
| description |
This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.
|
